TrialBreast cancer research and treatment2016

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance.

Giuseppe Viale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.